\
&
Contact us
\
&
Contact us
Starts in 1 week from now
LocationOnline
ProgrammesThis session aims to explore the call HORIZON-MISS-2026-01-CLIMA-07, which supports financing of local adaptation actions through public and private funding. Experts will provide insights into the policy context and innovative financing solutions for adaptation projects.
Following an initial presentation at the Horizon Europe Info Days, this session will feature contributions from the Adaptation Mission Manager, Elina Bardram, and EIB Deputy Director-General, Elina Roine, who will highlight the policy context and the importance of mobilising innovative financing solutions for local adaptation projects. The Mission Secretariat and the EIB will present the call in detail, while CINEA will clarify the applicable Horizon Europe rules, including Financial Support to Third Parties.
You can follow the livestream here.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
